Notch signaling in human development and disease.
Notch signaling in human development and disease.
复制标题
DOI:
10.1016/j.semcdb.2012.01.010
复制
发表时间:
2012-06
影响因子:
7.3
通讯作者:
Spinner, Nancy B.
中科院分区:
文献类型:
--
作者:
Penton, Andrea L.;Leonard, Laura D.;Spinner, Nancy B.
Mutations in Notch signaling pathway members cause developmental phenotypes that affect the liver, skeleton, heart, eye, face, kidney, and vasculature. Notch associated disorders include the autosomal dominant, multi-system, Alagille syndrome caused by mutations in both a ligand (Jagged1 (JAG1)) and receptor (NOTCH2) and autosomal recessive spondylocostal dysostosis, caused by mutations in a ligand (Delta-like-3 (DLL3)), as well as several other members of the Notch signaling pathway. Mutations in NOTCH2 have also recently been connected to Hajdu-Cheney syndrome, a dominant disorder causing focal bone destruction, osteoporosis, craniofacial morphology and renal cysts. Mutations in the NOTCH1 receptor are associated with several types of cardiac disease and mutations in NOTCH3 cause the dominant adult onset disorder CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a vascular disorder with onset in the 4th or 5th decades. Studies of these human disorders and their inheritance patterns and types of mutations reveal insights into the mechanisms of Notch signaling.
登录
查看更多内容
影响因子:
4.6
作者:
Hofmann, Jennifer J.;Zovein, Ann C.;Iruela-Arispe, M. Luisa
通讯作者:
Iruela-Arispe, M. Luisa
影响因子:
13.2
作者:
Jacquet, Antoine;Guiochon-Mantel, Anne;Fakhouri, Fadi
通讯作者:
Fakhouri, Fadi
影响因子:
3.5
作者:
Humphreys, Ryan;Zheng, Wei;Goudy, Steven
通讯作者:
Goudy, Steven
影响因子:
19.6
作者:
Cheng, HT;Kopan, R
通讯作者:
Kopan, R
影响因子:
13.5
作者:
Emerick, KM;Rand, EB;Piccoli, DA
通讯作者:
Piccoli, DA